Agite! is an Italian company, based in Milan, founded by a group of managers, entrepreneurs, lawyers and accountants. The goal of Agite! is to support teams of researchers with innovative technologies and business ideas in the foundation of start-up companies by providing the first Angel investment and giving step-by-step active guidance in the transition from scientists to entrepreneurs.

Antares is an investment company started in 1995 and controlled by Mario Zanone Poma and his family. Part of its investments are dedicated to innovative start-ups.

btov is a European venture capital firm, managing about €510m in institutional funds, partner funds and direct investments of private investors. btov teams in St.Gallen, Berlin, Munich and Luxemburg , together with seasoned entrepreneurs, back start-ups with teams willing to make the difference. btov is among the largest and oldest venture capital firms in Europe. Founded in 2000, originally as online matching platform named “BrainsToVentures”, btov has pioneered venture capital investment solutions for private, corporate and institutional investors.
https://btov.vc/

CDP Venture Capital SGR – Fondo Nazionale Innovazione CDP Venture Capital is an asset management company (of which 70% is held by CDP Equity and 30% by Invitalia) with an AuM of €1 billion. The mission of the firm is to make Venture Capital a strategic pillar to Italy's economic growth and innovation, creating the conditions for a comprehensive and sustainable growth of the Venture Capital ecosystem. It operates through a set of funds that aim to support startups in all their development phases and through a mix of direct and indirect investments.
https://www.cdpventurecapital.it

EUREKA! Venture SGR is an independent venture capital firm exclusively focused on deep tech investments. The firm manages Eureka! Fund I – Technology Transfer”: investments are focused on proof of concept, seed and early-stage deals in spinoffs and start-ups steaming out from Italian universities and research centers. Ideas and companies backed by Eureka! Fund has a competitive advantage stems from cutting-edge proprietary technologies and innovations in materials science with a clear and unique vision on intellectual property rights.
https://www.eurekaventure.it

F3F is an Italian company controlled by the biotech and healthcare entrepreneur Laura Iris Ferro. Based in Milan, the company has an investment policy aimed at taking stakes in diversified businesses with high return potential in traditional sectors such as real estate and in innovative sectors such as life sciences.

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven start-ups. With around € 900 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge almost 600 start-ups since 2005. Driven by their expertise, entrepreneurial spirit and passion, its team of experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial technology, life sciences, chemistry and related business areas. To date, external investors have injected over € 2.6 billion into the HTGF portfolio via more than 1,600 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in the public-private partnership include the Federal Ministry of Economics and Energy, KfW Capital, the Fraunhofer-Gesellschaft and 32 companies.
www.htgf.de/en

Founded in 2016, today Indaco Venture Partners SGR is the largest independent Italian venture capital asset management company, with a strong experience in companies that innovate in electronics and robotics, medtech, digital and new materials. Indaco manages over 250 million and has invested in WISE through three of its five funds: Atlante Seed, Atlante Ventures and Indaco Ventures I.
https://www.indacosgr.com/

Located in Padua (Italy), New Frontier Srl is a privately-owned Italian company focused on investments in innovative enterprises. New Frontier is attributable to the Family Office of the Rossi Luciani family, majority shareholder of Carel Industries, listed on the Milan Stock Exchange. It invests in start-up and early-stage companies with a high growth potential, with a particular focus on Italian companies in the bio-tech industry.

Xyence Capital is a European life sciences investment firm based in Milan. With a successful track record of over two decades in the space, Xyence has created a platform that turns new science into new products, improving outcomes for patients. Our aim is to help creating value for innovators, investors and healthcare systems.
https://xyence.vc/